Table 1.

Baseline demographic and clinical characteristics (N= 198)

Characteristic	Treatment				# F	p-value
	Citalopram (N = 104)		Placebo (N=94)
	Mean	SD	Mean	SD
Age (years)	53.14	7.68	51.70	6.33	2.032 (1,192)	0.156
Age at onset of first psychotic episode (years)	28.44	10.67	27.30	10.29	.484 (1,167)	0.488
Education level (years)	12.09	2.14	11.78	2.31	.938 (1,194)	0.334
Ham-17	13.59	4.39	13.38	4.08	.057(1,194)	0.812
CDRS	6.46	3.17	7.02	3.07	1957 (1,194)	0.163
	N	%	N	%	*χ2	P
Female gender	23	22.1	20	21.3	0.0149 (1)	0.903
Race					3.029 (3)	0.387
White	54	51.9	54	57.4
Black	40	38.5	26	27.7
Hispanic	5	4.8	9	5.3
Other	5	4.8	5	9.6
Marital status					15.169 (3)	0.002
Never (single)	32	30.8	48	51.1
Married or cohabitating	18	17.3	10	10.6
Divorced or separated	41	39.4	35	37.2
Widowed	13	12.5	1	1.1
Age< 18 years at onset of first psychotic episode	9	10.1	12	14.6	0.409 (1)	0.522
Diagnosed schizoaffective	48	46.2	33	35.1	1.521 (1)	0.218
Medications					0.036 (2)	0.982
Typical Antipsychotics	10	10.2	9	9.9
Atypical Antipsychotics	69	70.4	65	71.4
Both Typical and Atypical Antipsychotics	19	19.4	17	18.7
Anticholinergics	30	30.6	26	28.6	0.035 (1)	0.853

#F values with degrees of freedom in parentheses derived from Analysis of Covariance adjusting for baseline values, site and site by treatment interactions.

^*Mantel-Haenszel χ² with degrees of freedom in parentheses.